Review

Epigenetic regulation of UBE3A and roles in human neurodevelopmental disorders

Janine M LaSalle

*Author for correspondence:

E-mail Address: jmlasalle@ucdavis.edu

Medical Microbiology & Immunology, Genome Center & MIND Institute, University of California, Davis, CA 95616, USA

Search for more papers by this author

Lawrence T Reiter

Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38163, USA

Department of Neurology, University of Tennessee Health Science Center, Memphis, TN 38163, USA

Search for more papers by this author

Stormy J Chamberlain

Department of Genetics & Developmental Biology & Stem Cell Institute, University of Connecticut, Farmington, CT 06030, USA

Search for more papers by this author

Published Online:20 Nov 2015https://doi.org/10.2217/epi.15.70

View article

Abstract

The E3 ubiquitin ligase UBE3A, also known as E6-AP, has a multitude of ascribed functions and targets relevant to human health and disease. Epigenetic regulation of the UBE3A gene by parentally imprinted noncoding transcription within human chromosome 15q11.2–q13.3 is responsible for the maternal-specific effects of 15q11.2–q13.3 deletion or duplication disorders. Here, we review the evidence for diverse and emerging roles for UBE3A in the proteasome, synapse and nucleus in regulating protein stability and transcription as well as the current mechanistic understanding of UBE3A imprinting in neurons. Angelman and Dup15q syndromes as well as experimental models of these neurodevelopmental disorders are highlighted as improving understanding of UBE3A and its complex regulation for improving therapeutic strategies.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1 Tu Y, Chen C, Pan J, Xu J, Zhou ZG, Wang CY. The ubiquitin proteasome pathway (upp) in the regulation of cell cycle control and DNA damage repair and its implication in tumorigenesis. Int. J. Clin. Exp. Pathol. 5(8), 726–738 (2012).Medline, CAS, Google Scholar
2 Huibregtse JM, Scheffner M, Howley PM. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13(2), 775–784 (1993).• The first paper to identify the E3 ubiqutin ligase UBE3A as a protein associated with Papillomavirus E6 protein that mediates the degredation of p53.Crossref, Medline, CAS, Google Scholar
3 Cooper B, Schneider S, Bohl J, Jiang Y, Beaudet A, Vande Pol S. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53. Virology 306(1), 87–99 (2003).Crossref, Medline, CAS, Google Scholar
4 Kee Y, Huibregtse JM. Regulation of catalytic activities of HECT ubiquitin ligases. Biochem. Biophys. Res. Commun. 354(2), 329–333 (2007).Crossref, Medline, CAS, Google Scholar
5 Scheffner M, Staub O. HECT E3s and human disease. BMC Biochem. 8(Suppl. 1), S6 (2007).Crossref, Medline, Google Scholar
6 Huang L, Kinnucan E, Wang G et al. Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286(5443), 1321–1326 (1999).Crossref, Medline, CAS, Google Scholar
7 Ronchi VP, Klein JM, Haas AL. E6AP/UBE3A ubiquitin ligase harbors two E2 ubiquitin binding sites. J. Biol. Chem. 288(15), 10349–10360 (2013).Crossref, Medline, CAS, Google Scholar
8 Eletr ZM, Kuhlman B. Sequence determinants of E2-E6AP binding affinity and specificity. J. Mol. Biol. 369(2), 419–428 (2007).Crossref, Medline, CAS, Google Scholar
9 Ramamoorthy S, Nawaz Z. E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors. Nucl. Recept. Sig. 6, e006 (2008).Crossref, Medline, Google Scholar
10 Nawaz Z, Lonard DM, Smith CL et al. The angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 19(2), 1182–1189 (1999).• This was the first time E6AP/UBE3A was assigned a transcriptional coactivation function separate from the ubiqutin ligase function of the protein.Crossref, Medline, CAS, Google Scholar
11 Nawaz Z, Lonard DM, Dennis AP, Smith CL, O’Malley BW. Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl Acad. Sci. USA 96(5), 1858–1862 (1999).Crossref, Medline, CAS, Google Scholar
12 Catoe HW, Nawaz Z. E6-AP facilitates efficient transcription at estrogen responsive promoters through recruitment of chromatin modifiers. Steroids 76(9), 897–902 (2011).Medline, CAS, Google Scholar
13 Khan OY, Fu G, Ismail A et al. Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol. Endocrinol. 20(3), 544–559 (2006).Crossref, Medline, CAS, Google Scholar
14 James MA, Lee JH, Klingelhutz AJ. HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int. J. Cancer 119(8), 1878–1885 (2006).Crossref, Medline, CAS, Google Scholar
15 Jensen LJ, Farook MF, Reiter LT. Proteomic profiling in Drosophila reveals potential Dube3a regulation of the actin cytoskeleton and neuronal homeostasis. PLoS ONE 8(4), e61952 (2013).Crossref, Medline, CAS, Google Scholar
16 Ferdousy F, Bodeen W, Summers K et al. Drosophila UBE3A regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism. Neurobiol. Dis. 41(3), 669–677 (2011).Crossref, Medline, CAS, Google Scholar
17 El Hokayem J, Nawaz Z. E6AP in the brain: one protein, dual function, multiple diseases. Mol. Neurobiol. 49(2), 827–839 (2014).Crossref, Medline, CAS, Google Scholar
18 Germain ND, Chen PF, Plocik AM et al. Gene expression analysis of human induced pluripotent stem cell-derived neurons carrying copy number variants of chromosome 15q11–q13.1. Mol. Autism 5, 44 (2014).Crossref, Medline, Google Scholar
19 Miao S, Chen R, Ye J et al. The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. J. Neurosci. 33(1), 327–333 (2013).Crossref, Medline, CAS, Google Scholar
20 Greer PL, Hanayama R, Bloodgood BL et al. The Angelman syndrome protein Ube3a regulates synapse development by ubiquitinating arc. Cell 140(5), 704–716 (2010).Crossref, Medline, CAS, Google Scholar
21 RefSeq: NCBI. www.ncbi.nlm.nih.gov/refseq/Google Scholar
22 GeneCards: The Human Gene Database. www.genecards.orgGoogle Scholar
23 Dindot SV, Antalffy BA, Bhattacharjee MB et al. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 17(1), 111–118 (2008). • Provided a key reagent (Ube3a-GFP mice) to demonstrate paternal expression of Ube3a in specific brain regions, the observation of abnormal dendritic spine morphology, and the cellular localization of Ube3a to both the synapse and nucleus.Crossref, Medline, CAS, Google Scholar
24 Yashiro K, Riday TT, Condon KH et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12(6), 777–783 (2009).Crossref, Medline, CAS, Google Scholar
25 Mabb AM, Ehlers MD. Ubiquitination in postsynaptic function and plasticity. Ann. Rev. Cell Dev. Biol. 26, 179–210 (2010).Crossref, Medline, CAS, Google Scholar
26 Valluy J, Bicker S, Aksoy-Aksel A et al. A coding-independent function of an alternative Ube3a transcript during neuronal development. Nat. Neurosci. 18(5), 666–673 (2015).Crossref, Medline, CAS, Google Scholar
27 BioGRID: results summary. http://thebiogrid.org/113185/summary/homo-sapiens/ube3a.htmlGoogle Scholar
28 Jacobson AD, Macfadden A, Wu Z, Peng J, Liu CW. Autoregulation of the 26S proteasome by in situ ubiquitination. Mol. Biol. Cell 25(12), 1824–1835 (2014).Crossref, Medline, CAS, Google Scholar
29 Wang X, Chen CF, Baker PR, Chen PL, Kaiser P, Huang L. Mass spectrometric characterization of the affinity-purified human 26S proteasome complex. Biochemistry 46(11), 3553–3565 (2007).Crossref, Medline, CAS, Google Scholar
30 Schwarz SE, Rosa JL, Scheffner M. Characterization of human HECT domain family members and their interaction with UbcH5 and UbcH7. J. Biol. Chem. 273(20), 12148–12154 (1998).Crossref, Medline, CAS, Google Scholar
31 Ronchi VP, Klein JM, Edwards DJ, Haas AL. The active form of E6-associated protein (E6AP)/UBE3A ubiquitin ligase is an oligomer. J. Biol. Chem. 289(2), 1033–1048 (2014).Crossref, Medline, CAS, Google Scholar
32 Zaaroor-Regev D, De Bie P, Scheffner M et al. Regulation of the polycomb protein Ring1B by self-ubiquitination or by E6-AP may have implications to the pathogenesis of angelman syndrome. Proc. Natl Acad. Sci. USA 107(15), 6788–6793 (2010).Crossref, Medline, CAS, Google Scholar
33 Kuhnle S, Kogel U, Glockzin S et al. Physical and functional interaction of the HECT ubiquitin-protein ligases E6AP and HERC2. J. Biol. Chem. 286(22), 19410–19416 (2011).Crossref, Medline, Google Scholar
34 Nasu J, Murakami K, Miyagawa S et al. E6AP ubiquitin ligase mediates ubiquitin-dependent degradation of peroxiredoxin 1. J. Cell. Biochem. 111(3), 676–685 (2010).Crossref, Medline, CAS, Google Scholar
35 Picard N, Charbonneau C, Sanchez M et al. Phosphorylation of activation function-1 regulates proteasome-dependent nuclear mobility and E6-associated protein ubiquitin ligase recruitment to the estrogen receptor beta. Mol. Endocrin. 22(2), 317–330 (2008).Crossref, Medline, CAS, Google Scholar
36 Gossan NC, Zhang F, Guo B et al. The E3 ubiquitin ligase UBE3A is an integral component of the molecular circadian clock through regulating the BMAL1 transcription factor. Nucleic Acids Res. 42(9), 5765–5775 (2014).Crossref, Medline, CAS, Google Scholar
37 Shi SQ, Bichell TJ, Ihrie RA, Johnson CH. Ube3a imprinting impairs circadian robustness in Angelman syndrome models. Curr. Biol. 25(5), 537–545 (2015).Crossref, Medline, CAS, Google Scholar
38 Margolis SS, Salogiannis J, Lipton DM et al. EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell 143(3), 442–455 (2010).Crossref, Medline, CAS, Google Scholar
39 Reiter LT, Seagroves TN, Bowers M, Bier E. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase. Hum. Mol. Genet. 15(18), 2825–2835 (2006).Crossref, Medline, CAS, Google Scholar
40 Kumar S, Talis AL, Howley PM. Identification of HHR23A as a substrate for E6-associated protein-mediated ubiquitination. J. Biol. Chem. 274(26), 18785–18792 (1999).Crossref, Medline, CAS, Google Scholar
41 Mishra A, Godavarthi SK, Maheshwari M, Goswami A, Jana NR. The ubiquitin ligase E6-AP is induced and recruited to aggresomes in response to proteasome inhibition and may be involved in the ubiquitination of HSP70-bound misfolded proteins. J. Biol. Chem. 284(16), 10537–10545 (2009).Crossref, Medline, CAS, Google Scholar
42 Zheng L, Ding H, Lu Z et al. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Genes Cells 13(3), 285–294 (2008).Crossref, Medline, CAS, Google Scholar
43 Sun J, Liu Y, Moreno S, Baudry M, Bi X. Imbalanced mechanistic target of rapamycin C1 and C2 activity in the cerebellum of Angelman syndrome mice impairs motor function. J. Neurosci. 35(11), 4706–4718 (2015).Crossref, Medline, CAS, Google Scholar
44 Lee SY, Ramirez J, Franco M et al. Ube3a, the E3 ubiquitin ligase causing angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle RPN10. Cell. Mol. Life Sci. 71(14), 2747–2758 (2014).• The UBE3A substrate RPN10 is a shuttle protein for the ubiquitin proteasome system, so the downstream regulation of multiple proteins could have profound effects on UBE3A-related disorders.Crossref, Medline, CAS, Google Scholar
45 Galligan JT, Martinez-Noel G, Arndt V et al. Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J. Proteome Res. 14(2), 953–966 (2015).Crossref, Medline, CAS, Google Scholar
46 Tan WH, Bird LM, Thibert RL, Williams CA. If not Angelman, what is it? A review of Angelman-like syndromes. Am. J. Med Genet. 164A(4), 975–992 (2014).Crossref, Medline, Google Scholar
47 Jedele KB. The overlapping spectrum of rett and angelman syndromes: a clinical review. Sem. Ped. Neurol. 14(3), 108–117 (2007).Crossref, Medline, Google Scholar
48 Thibert RL, Larson AM, Hsieh DT, Raby AR, Thiele EA. Neurologic manifestations of Angelman syndrome. Ped. Neurol. 48(4), 271–279 (2013).• An EEG pattern was identified that is unique to Angelman syndrome (AS).Crossref, Google Scholar
49 Chamberlain SJ, Lalande M. Angelman syndrome, a genomic imprinting disorder of the brain. J. Neurosci. 30(30), 9958–9963 (2010).Crossref, Medline, CAS, Google Scholar
50 Sadikovic B, Fernandes P, Zhang VW et al. Mutation update for UBE3A variants in Angelman syndrome. Hum. Mut. 35(12), 1407–1417 (2014).Crossref, Medline, CAS, Google Scholar
51 Fang P, Lev-Lehman E, Tsai TF et al. The spectrum of mutations in UBE3A causing Angelman syndrome. Hum. Mol. Genet. 8(1), 129–135 (1999).Crossref, Medline, CAS, Google Scholar
52 Mertz LG, Thaulov P, Trillingsgaard A et al. Neurodevelopmental outcome in Angelman syndrome: genotype-phenotype correlations. Res. Dev. Disabil. 35(7), 1742–1747 (2014).Crossref, Medline, Google Scholar
53 Sahoo T, Peters SU, Madduri NS et al. Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations. J. Med. Genet. 43(6), 512–516 (2006).Crossref, Medline, CAS, Google Scholar
54 Bonati MT, Russo S, Finelli P et al. Evaluation of autism traits in angelman syndrome: a resource to unfold autism genes. Neurogenetics 8(3), 169–178 (2007).Crossref, Medline, CAS, Google Scholar
55 Peters SU, Beaudet AL, Madduri N, Bacino CA. Autism in angelman syndrome: implications for autism research. Clin. Genet. 66(6), 530–536 (2004).Crossref, Medline, CAS, Google Scholar
56 Valente KD, Fridman C, Varela MC et al. Angelman syndrome: uniparental paternal disomy 15 determines mild epilepsy, but has no influence on EEG patterns. Epilepsy Res. 67(3), 163–168 (2005).Crossref, Medline, Google Scholar
57 Valente KD, Varela MC, Koiffmann CP et al. Angelman syndrome caused by deletion: a genotype-phenotype correlation determined by breakpoint. Epilepsy Res. 105(1–2), 234–239 (2013).Crossref, Medline, CAS, Google Scholar
58 Mertz LG, Christensen R, Vogel I, Hertz JM, Ostergaard JR. Eating behavior, prenatal and postnatal growth in angelman syndrome. Res. Dev. Disabil. 35(11), 2681–2690 (2014).Crossref, Medline, Google Scholar
59 Brennan ML, Adam MP, Seaver LH et al. Increased body mass in infancy and early toddlerhood in angelman syndrome patients with uniparental disomy and imprinting center defects. Am. J. Med. Genet. Part A 167A(1), 142–146 (2015).Crossref, Medline, Google Scholar
60 Hogart A, Leung KN, Wang NJ et al. Chromosome 15q11–13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J. Med. Genet. 46(2), 86–93 (2009).Crossref, Medline, CAS, Google Scholar
61 UCSC Genome Browser. http://genomebrowser.wustl.eduGoogle Scholar
62 Rougeulle C, Cardoso C, Fontes M, Colleaux L, Lalande M. An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nat. Genet. 19(1), 15–16 (1998).Crossref, Medline, CAS, Google Scholar
63 Runte M, Huttenhofer A, Gross S, Kiefmann M, Horsthemke B, Buiting K. The IC-SNURF-SNRPN transcript serves as a host for multiple small nucleolar RNA species and as an antisense RNA for UBE3A. Hum. Mol. Genet. 10(23), 2687–2700 (2001).Crossref, Medline, CAS, Google Scholar
64 Yamasaki K, Joh K, Ohta T et al. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Hum. Mol. Genet. 12(8), 837–847 (2003).Crossref, Medline, CAS, Google Scholar
65 Meng L, Person RE, Beaud et al. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Hum. Mol. Genet. 21(13), 3001–3012 (2012).Crossref, Medline, CAS, Google Scholar
66 Sahoo T, Del Gaudio D, German JR et al. Prader–Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat. Genet. 40(6), 719–721 (2008).Crossref, Medline, CAS, Google Scholar
67 Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader–Willi syndrome. Genet. Med. 14(1), 10–26 (2012).Crossref, Medline, CAS, Google Scholar
68 Powell WT, Coulson RL, Gonzales ML et al. R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc. Natl Acad. Sci. USA 110(34), 13938–13943 (2013).Crossref, Medline, CAS, Google Scholar
69 Powell WT, Coulson RL, Crary FK et al. A Prader–Willi locus lncRNA cloud modulates diurnal genes and energy expenditure. Hum. Mol. Genet. 22(21), 4318–4328 (2013).Crossref, Medline, CAS, Google Scholar
70 Vitali P, Royo H, Marty V, Bortolin-Cavaille ML, Cavaille J. Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snorna gene arrays. J. Cell. Sci. 123(Pt 1), 70–83 (2010).Crossref, Medline, CAS, Google Scholar
71 Martins-Taylor K, Hsiao JS, Chen PF et al. Imprinted expression of UBE3A in non-neuronal cells from a Prader–Willi syndrome patient with an atypical deletion. Hum. Mol. Genet. 23(9), 2364–2373 (2014).Crossref, Medline, CAS, Google Scholar
72 Buiting K, Gross S, Lich C, Gillessen-Kaesbach G, El-Maarri O, Horsthemke B. Epimutations in Prader–Willi and Angelman syndromes: a molecular study of 136 patients with an imprinting defect. Am. J. Hum. Genet. 72(3), 571–577 (2003).Crossref, Medline, CAS, Google Scholar
73 Hiura H, Okae H, Miyauchi N et al. Characterization of DNA methylation errors in patients with imprinting disorders conceived by assisted reproduction technologies. Hum. Reprod. 27(8), 2541–2548 (2012).Crossref, Medline, CAS, Google Scholar
74 Arnaud P, Feil R. Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. Birth Defects Res. 75(2), 81–97 (2005).Crossref, CAS, Google Scholar
75 Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. Bisphenol a exposure disrupts genomic imprinting in the mouse. PLoS Genet. 9(4), e1003401 (2013).Crossref, Medline, CAS, Google Scholar
76 Le Meur E, Watrin F, Landers M, Sturny R, Lalande M, Muscatelli F. Dynamic developmental regulation of the large non-coding RNA associated with the mouse 7C imprinted chromosomal region. Dev. Biol. 286(2), 587–600 (2005).Crossref, Medline, CAS, Google Scholar
77 Landers M, Bancescu DL, Le Meur E et al. Regulation of the large (approximately 1000 kb) imprinted murine Ube3a antisense transcript by alternative exons upstream of Snurf/Snrpn. Nucleic Acids Res. 32(11), 3480–3492 (2004).Crossref, Medline, CAS, Google Scholar
78 Lewis MW, Brant JO, Kramer JM et al. Angelman syndrome imprinting center encodes a transcriptional promoter. Proc. Natl Acad. Sci. USA 112(22), 6871–6875 (2014).Crossref, Medline, Google Scholar
79 Jiang YH, Armstrong D, Albrecht U et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron 21(4), 799–811 (1998).• The first mouse model of AS recapitulated both seizure and ataxia phenotypes and maternal-specific expression of UBE3A in the brain.Crossref, Medline, CAS, Google Scholar
80 Yashiro K, Riday TT, Condon KH et al. Ube3a is required for experience-dependent maturation of the neocortex. Nat. Neurosci. 12(6), 777–783 (2009).Crossref, Medline, CAS, Google Scholar
81 Miura K, Kishino T, Li E et al. Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice. Neurobiol. Dis. 9(2), 149–159 (2002).Crossref, Medline, CAS, Google Scholar
82 Colas D, Wagstaff J, Fort P, Salvert D, Sarda N. Sleep disturbances in Ube3a maternal-deficient mice modeling Angelman syndrome. Neurobiol. Dis. 20(2), 471–478 (2005).Crossref, Medline, CAS, Google Scholar
83 Jiang YH, Pan Y, Zhu L et al. Altered ultrasonic vocalization and impaired learning and memory in Angelman syndrome mouse model with a large maternal deletion from Ube3a to Gabrb3. PLoS ONE 5(8), e12278 (2010).Crossref, Medline, Google Scholar
84 Gabriel JM, Merchant M, Ohta T et al. A transgene insertion creating a heritable chromosome deletion mouse model of Prader–Willi and Angelman syndromes. Proc. Natl Acad. Sci. USA 96(16), 9258–9263 (1999).Crossref, Medline, CAS, Google Scholar
85 Wu MY, Chen KS, Bressler J et al. Mouse imprinting defect mutations that model Angelman syndrome. Genesis 44(1), 12–22 (2006).Crossref, Medline, CAS, Google Scholar
86 Chamberlain SJ, Chen PF, Ng KY et al. Induced pluripotent stem cell models of the genomic imprinting disorders Angelman and Prader–Willi syndromes. Proc. Natl Acad. Sci. USA 107(41), 17668–17673 (2010).• This was the first demonstration of induced pluripotent stem cells derived from human Prader–Willi syndrome and AS patients that showed maintenance of neuronal imprinting and expression of the UBE3A-antisense transcript in induced pluripotent stem cell-derived neurons.Crossref, Medline, CAS, Google Scholar
87 Huang HS, Allen JA, Mabb AM et al. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature 481(7380), 185–189 (2012).Crossref, CAS, Google Scholar
88 King IF, Yandava CN, Mabb AM et al. Topoisomerases facilitate transcription of long genes linked to autism. Nature 501(7465), 58–62 (2013).Crossref, Medline, CAS, Google Scholar
89 Mabb AM, Kullmann PH, Twomey MA, Miriyala J, Philpot BD, Zylka MJ. Topoisomerase 1 inhibition reversibly impairs synaptic function. Proc. Natl Acad. Sci. USA 111(48), 17290–17295 (2014).Crossref, Medline, CAS, Google Scholar
90 Meng L, Ward AJ, Chun S, Bennett CF, Beaudet AL, Rigo F. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA. Nature 518(7539), 409–412 (2015).• Demonstrates that in the mouse model for AS, noncoding RNAs can be used in vivo to decrease UBE3A-antisense transcript and rescue some of the neurological phenotypes of the disorder.Crossref, Medline, CAS, Google Scholar
91 Silva-Santos S, Van Woerden GM, Bruinsma CF et al. Ube3a reinstatement identifies distinct developmental windows in a murine angelman syndrome model. J. Clin. Invest. 125(5), 2069–2076 (2015).Crossref, Medline, Google Scholar
92 Mandel-Brehm C, Salogiannis J, Dhamne SC, Rotenberg A, Greenberg ME. Seizure-like activity in a juvenile angelman syndrome mouse model is attenuated by reducing arc expression. Proc. Natl Acad. Sci. USA 112(16), 5129–5134 (2015).Crossref, Medline, CAS, Google Scholar
93 Hogart A, Wu D, Lasalle JM, Schanen NC. The comorbidity of autism with the genomic disorders of chromosome 15q11.2–q13. Neurobiol. Dis. 38(2), 181–191 (2010).Crossref, Medline, CAS, Google Scholar
94 Urraca N, Cleary J, Brewer V et al. The interstitial duplication 15q11.2–q13 syndrome includes autism, mild facial anomalies and a characteristic EEG signature. Autism Res. 6(4), 268–279. (2013).Crossref, Medline, Google Scholar
95 Wang NJ, Parokonny AS, Thatcher KN et al. Multiple forms of atypical rearrangements generating supernumerary derivative chromosome 15. BMC Genet. 9, 2 (2008).Crossref, Medline, Google Scholar
96 Battaglia A. The inv dup (15) or idic (15) syndrome (tetrasomy 15q). Orphanet. J. Rare Dis. 3, 30 (2008).Crossref, Medline, Google Scholar
97 Conant KD, Finucane B, Cleary N et al. A survey of seizures and current treatments in 15q duplication syndrome. Epilepsia 55(3), 396–402 (2014).Crossref, Medline, CAS, Google Scholar
98 Noor A, Dupuis L, Mittal K et al. 15q11.2 duplication encompassing only the Ube3a gene is associated with developmental delay and neuropsychiatric phenotypes. Hum. Mut. 36(7), 689–693 (2015).Crossref, Medline, CAS, Google Scholar
99 Cook EH Jr., Lindgren V, Leventhal BL et al. Autism or atypical autism in maternally but not paternally derived proximal 15q duplication. Am. J. Hum. Genet. 60(4), 928–934 (1997).Medline, CAS, Google Scholar
100 Al Ageeli E, Drunat S, Delanoe C et al. Duplication of the 15q11–q13 region: clinical and genetic study of 30 new cases. Eur. J. Med. Genet. 57(1), 5–14 (2014).Crossref, Medline, Google Scholar
101 Ogata H, Ihara H, Murakami N, Gito M, Kido Y, Nagai T. Autism spectrum disorders and hyperactive/impulsive behaviors in japanese patients with Prader–Willi syndrome: a comparison between maternal uniparental disomy and deletion cases. Am. J. Med. Genet. A 164A(9), 2180–2186 (2014).Crossref, Medline, Google Scholar
102 Dykens EM, Lee E, Roof E. Prader–Willi syndrome and autism spectrum disorders: an evolving story. J. Neurodev. Disord. 3(3), 225–237 (2011).Crossref, Medline, Google Scholar
103 Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl. Med. 3(103), 103ra197 (2011).Crossref, Google Scholar
104 Salvat C, Wang G, Dastur A, Lyon N, Huibregtse JM. The -4 phenylalanine is required for substrate ubiquitination catalyzed by HECT ubiquitin ligases. J. Biol. Chem. 279(18), 18935–18943 (2004).Crossref, Medline, CAS, Google Scholar
105 Kuhnle S, Mothes B, Matentzoglu K, Scheffner M. Role of the ubiquitin ligase E6AP/Ube3a in controlling levels of the synaptic protein arc. Proc. Natl Acad. Sci. USA 110(22), 8888–8893 (2013).Crossref, Medline, Google Scholar
106 Nakatani J, Tamada K, Hatanaka F et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11–13 duplication seen in autism. Cell 137(7), 1235–1246 (2009).Crossref, Medline, Google Scholar
107 Meguro-Horike M, Yasui DH, Powell W et al. Neuron-specific impairment of inter-chromosomal pairing and transcription in a novel model of human 15q-duplication syndrome. Hum. Mol. Genet. 20(19), 3798–3810 (2011).Crossref, Medline, CAS, Google Scholar
108 Brennand K, Savas JN, Kim Y et al. Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia. Mol. Psych. 20(3), 361–368 (2014).Crossref, Medline, Google Scholar
109 Wegiel J, Frackowiak J, Mazur-Kolecka B et al. Abnormal intracellular accumulation and extracellular abeta deposition in idiopathic and Dup15q11.2–q13 autism spectrum disorders. PLoS ONE 7(5), e35414 (2012).Crossref, Medline, CAS, Google Scholar
110 Voineagu I, Wang X, Johnston P et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474(7351), 380–384 (2011).Crossref, Medline, CAS, Google Scholar
111 Yasui DH, Scoles HA, Horike S et al. 15q11.2–13.3 chromatin analysis reveals epigenetic regulation of CHRNA7 with deficiencies in Rett and autism brain. Hum. Mol. Genet. 20(22), 4311–4323 (2011).Crossref, Medline, CAS, Google Scholar
112 Harlalka GV, Baple EL, Cross H et al. Mutation of HERC2 causes developmental delay with Angelman-like features. J. Med. Genet. 50(2), 65–73 (2013).Crossref, Medline, CAS, Google Scholar

Vol. 7, No. 7

Metrics

Downloaded 471 times

History

Published online 20 November 2015

Published in print October 2015

Information

Keywords

Acknowledgements

The authors thank the Dup15q Alliance scientific advisory board members, particularly O Devinsky and S Jeste for their critical review of the manuscript and helpful comments.

Financial & competing interests disclosure

The authors thank the NIH NINDS (R01NS076263) and the Prader–Willi Research Foundation for ongoing support of research in this area. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

PDF download